Unibest

Pharmaceutical intermediates

Levofloxacin Intermediates

1 pharmaceutical intermediate for Levofloxacin. Indication: Respiratory tract infection; Cystic fibrosis; Bacterial infection.

Submit a ProjectAll intermediates

About Levofloxacin

Originator
Johnson & Johnson
Indication
Respiratory tract infection; Cystic fibrosis; Bacterial infection
Approved Date
12/20/1996

Available intermediates

1 intermediate currently listed for Levofloxacin. Request specifications, documentation or a quotation for any item below.

Levofloxacin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Levofloxacin carboxylic acid100986-89-8//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Levofloxacin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →